eprintid: 10040273 rev_number: 24 eprint_status: archive userid: 608 dir: disk0/10/04/02/73 datestamp: 2017-12-19 11:22:28 lastmod: 2020-06-09 09:54:27 status_changed: 2017-12-19 11:22:28 type: article metadata_visibility: show creators_name: Ryerson, CJ creators_name: Denton, CP title: The Fine Line Between Success and Failure in Scleroderma Lung Fibrosis Trials ispublished: pub subjects: RFH divisions: UCL divisions: A01 divisions: B02 divisions: C10 divisions: D17 divisions: G90 keywords: Forced vital capacity, Interstitial lung disease, Minimum clinically important difference, Outcomes, Systemic sclerosis note: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. date: 2017 date_type: published official_url: https://doi.org/10.1164/rccm.201711-2268ED oa_status: green full_text_type: other language: eng primo: open primo_central: open_green article_type_text: Journal Article verified: verified_manual elements_id: 1513564 doi: 10.1164/rccm.201711-2268ED lyricists_name: Denton, Christopher lyricists_id: CPDEN87 actors_name: Denton, Christopher actors_id: CPDEN87 actors_role: owner full_text_status: public publication: American Journal of Respiratory and Critical Care Medicine volume: 197 number: 5 pagerange: 553-554 event_location: United States issn: 1535-4970 citation: Ryerson, CJ; Denton, CP; (2017) The Fine Line Between Success and Failure in Scleroderma Lung Fibrosis Trials. American Journal of Respiratory and Critical Care Medicine , 197 (5) pp. 553-554. 10.1164/rccm.201711-2268ED <https://doi.org/10.1164/rccm.201711-2268ED>. Green open access document_url: https://discovery.ucl.ac.uk/id/eprint/10040273/1/Ryerson%20and%20Denton%202017%20editorial%20reprint%20AJRCCM.pdf